HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A biocompatible and injectable hydrogel to boost the efficacy of stem cells in neurodegenerative diseases treatment.

AbstractAIMS:
Stem cell therapies emerged as treatment modalities with potential to cure neurodegenerative diseases (NDs). However, despite high expectations, their clinical use is still limited. Critical issues in treatment outcomes may be related to stem cells formulation and administration route. We develop a hydrogel as a cell carrier, consisting of compounds (phospholipids and hyaluronic acid-HA) naturally present in the central nervous system (CNS). The HA-based hydrogel physically crosslinked with liposomes is designed for direct injection into the CNS to significantly increase the bone marrow mesenchymal stem cells (BMSCs) bioavailability.
MATERIALS AND METHODS:
Hydrogel compatibility is confirmed in vitro with BMSCs and in vivo through its intracerebroventricular injection in rats. To assess its efficacy, the main cause of chronic neurologic disability in young adults is selected, namely multiple sclerosis (MS). The efficacy of the developed formulation containing a lower number of cells than previously reported is demonstrated using an experimental autoimmune encephalomyelitis (EAE) rat model.
KEY FINDINGS:
The distribution of the engineered hydrogel into corpus callosum can be ideal for NDs treatment, since damage of this white matter structure is responsible for important neuronal deficits. Moreover, the BMSCs-laden hydrogel significantly decreases disease severity and maximum clinical score and eliminated the relapse.
SIGNIFICANCE:
The engineering of advanced therapies using this natural carrier can result in efficacious treatments for MS and related debilitating conditions.
AuthorsHelena Ferreira, Diana Amorim, Ana Cláudia Lima, Rogério P Pirraco, Ana Rita Costa-Pinto, Rui Almeida, Armando Almeida, Rui L Reis, Filipa Pinto-Ribeiro, Nuno M Neves
JournalLife sciences (Life Sci) Vol. 287 Pg. 120108 (Dec 15 2021) ISSN: 1879-0631 [Electronic] Netherlands
PMID34717909 (Publication Type: Journal Article)
CopyrightCopyright © 2021 Elsevier Inc. All rights reserved.
Chemical References
  • Biocompatible Materials
  • Hydrogels
  • Liposomes
Topics
  • Animals
  • Biocompatible Materials (administration & dosage, chemical synthesis, metabolism)
  • Cell Survival (drug effects, physiology)
  • Cells, Cultured
  • Encephalomyelitis, Autoimmune, Experimental (metabolism, therapy)
  • Female
  • Hydrogels (administration & dosage, chemical synthesis, metabolism)
  • Liposomes
  • Male
  • Mesenchymal Stem Cells (metabolism)
  • Neurodegenerative Diseases (metabolism, therapy)
  • Rats
  • Rats, Inbred Lew
  • Rats, Wistar
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: